1. Home
  2. HLMN vs XERS Comparison

HLMN vs XERS Comparison

Compare HLMN & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hillman Solutions Corp.

HLMN

Hillman Solutions Corp.

HOLD

Current Price

$8.44

Market Cap

1.5B

ML Signal

HOLD

XERS

Xeris Biopharma Holdings Inc.

HOLD

Current Price

$7.92

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLMN
XERS
Founded
1964
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
HLMN
XERS
Price
$8.44
$7.92
Analyst Decision
Strong Buy
Buy
Analyst Count
5
6
Target Price
$11.60
$10.83
AVG Volume (30 Days)
2.1M
1.9M
Earning Date
04-27-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
122.22
100.00
EPS
N/A
0.01
Revenue
$1,552,224,000.00
$49,590,000.00
Revenue This Year
$7.65
$34.37
Revenue Next Year
$4.67
$22.86
P/E Ratio
N/A
$774.00
Revenue Growth
5.41
142.67
52 Week Low
$6.96
$4.52
52 Week High
$10.85
$10.08

Technical Indicators

Market Signals
Indicator
HLMN
XERS
Relative Strength Index (RSI) 65.30 79.99
Support Level $7.76 $7.78
Resistance Level $8.59 $8.43
Average True Range (ATR) 0.32 0.27
MACD 0.10 0.11
Stochastic Oscillator 95.31 97.59

Price Performance

Historical Comparison
HLMN
XERS

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S, Canada and Mexico.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

Share on Social Networks: